Organoids usually refer to a collection of cells with specific organ functions formed in the laboratory through cell culture techniques. They are usually composed of a group of cells with the same or similar functions and have morphological and functional characteristics similar to organs. Organoids have wide applications in the fields of medicine, biology, and bioengineering, such as disease modeling, drug screening, and regenerative medicine.

The organoid market is currently in its early stages, but with the continuous development and application of biotechnology, the market size is expected to grow rapidly. According to our prediction, the total revenue of the global organoid market may reach $97 million in 2023.

At present, the common types of organoids include intestinal organoids, hepatic organoids, pancreatic organoids, and neural organoids. Among them, the intestinal organ segment market holds a dominant position. Based on our research data, the global market revenue share of intestinal organs is expected to reach 35.49% in 2023. From the perspective of downstream users, the revenue of biopharmaceutical companies in the organoid market is expected to account for 62.37% of the entire downstream application market in 2023.

Source: www.globalmarketmonitor.com

From the perspective of market competition pattern, the concentration of the global organoid market is moderate. Data shows that the revenue of the top 3 enterprises organoid market in the industry totaled $28 million in 2020, accounting for 43.22% of the market. The total revenue of the top 6 enterprises was $39, with a total market share of 60.87%. The top three companies in the rankings were STEMCELL Technology, Hubrecht Organoid Technology (HUB), and DefiniGEN. In 2020, the organoid market revenue of the three companies accounted for 23.16%, 11.17%, and 8.89% of the global market, respectively.

Global Organoid Market Revenue and Market Share by Enterprise in 2020

Enterprises	Market Revenue (M USD)	Market Share
STEMCELL Technologie	15	23.16%
Hubrecht Organoid Technology (HUB)	7	11.17%
DefiniGEN	6	8.89%
Top3 Enterprises	28	43.22%
Top6 Enterprises	39	60.87%

Source: www.globalmarketmonitor.com

Although the widespread application of organoid technology in the research community is still in its early stages, as a tool, organoid technology has great potential in researching developmental biology, disease pathology, cell biology, regeneration mechanisms, precision medicine, as well as drug toxicity and efficacy testing. In the future, with the continuous development of organoid culture systems and their experimental development technologies, the application of organoids will continue to expand to more fields.